6 research outputs found

    Técnicas de equalização iterativa para arquiteturas híbridas sub-conectadas na banda de ondas milimétricas

    Get PDF
    Mestrado em Engenharia Eletrónica e TelecomunicaçõesThe millimeter wave communications and the use of a massive number of antennas are two promising technologies that being combined allow to achieve the multi Gb/s required by future 5G wireless systems. As this type of systems has a high number of antennas it is impossible to use a fully digital architecture, due to hardware limitations. Therefore, the design of signal processing techniques for hybrid analog-digital architectures is a requirement. Depending on the structure of the analog part the hybrid analog-digital architectures may be fully connected or sub-connected. Although the fully connected hybrid architectures allow to connect all RF chains to any antenna element, they involve a high cost due to its structural and computational complexity. As such, the sub-connected hybrid architectures become more attractive, since either at the hardware level or from the computational point of view they are less demanding. In this dissertation, we propose a hybrid iterative block multiuser equalizer for sub-connected millimeter wave massive MIMO systems. The user terminal transceiver has low-complexity and as such employ a pure analog random precoder, with a single RF chain. For the base station, a sub-connected hybrid analog-digital equalizer is designed to remove the multiuser interference. The hybrid equalizer is optimized using the average bit-error-rate as a metric. Due to the coupling between the RF chains in the optimization problem the computation of the optimal solution is way too complex. To address this problem, we compute the analog part of the equalizer sequentially over the RF chains using a dictionary built from the array response vectors. The proposed sub-connected hybrid iterative multiuser equalizer is compared with a recently proposed fully connected hybrid analog-digital approach and with the fully digital architecture. The results show that the performance of the proposed scheme is close to the fully connected hybrid approach after just a few iterations.As comunicações na banda das ondas milimétricas e o uso massivo de antenas são duas tecnologias promissoras que, sendo combinadas permitem alcançar elevadas taxas de transmissão, na ordem dos multi Gb/s, exigidas pelos futuros sistemas sem fios da 5G. Como estes sistemas possuem um número elevado de antenas, torna-se impossível o uso de uma arquitetura totalmente digital devido às limitações de hardware. Desta forma, é necessário projetar técnicas de processamento de sinal para arquiteturas híbridas analógico-digitais. Dentro das arquiteturas híbridas, foram propostas duas formas de lidar com a parte analógica, que são, a forma totalmente conectada e a forma sub-conectada. Embora as arquiteturas híbridas totalmente conectadas permitam interligar todas as cadeias RF a qualquer elemento de antena, estas envolvem um elevado custo devido à sua complexidade estrutural e computacional. Assim sendo, as arquiteturas híbridas sub-conectadas tornam-se mais atraentes pois são menos exigentes do ponto de vista computacional, bem como ao nível do hardware. Nesta dissertação, é proposto um equalizador iterativo para um sistema com uma arquitetura hibrida sub-conectada, com múltiplos utilizadores e um número massivo de antenas a operar na banda das ondas milimétricas. Os terminais dos utilizadores têm baixa complexidade e utilizam pré-codificadores aleatórios analógicos puros, cada um com uma única cadeia RF. Para a estação base, projetou-se um equalizador híbrido analógico-digital de arquitectura sub-conectada, para remover a interferência multiutilizador. O equalizador híbrido é otimizado usando a taxa média de erro de bit como métrica. Devido ao acoplamento entre as cadeias de RF no problema de otimização, o cálculo das soluções ótimas possui elevada complexidade. Para ultrapassar este problema, calculou-se a parte analógica de cada cadeia de RF do equalizador de forma sequencial, usando um dicionário construído a partir da resposta do agregado de antenas. Compara-se o equalizador iterativo híbrido para sistemas multiutilizador de arquitectura sub-conectada proposto com uma abordagem híbrida analógica/digital totalmente conectada, recentemente proposta na literatura e com uma arquitetura totalmente digital. Os resultados mostram que o desempenho do esquema proposto aproximasse da abordagem híbrida totalmente conectada após apenas algumas iterações

    Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

    Full text link
    The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

    The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections

    Full text link
    Purpose: The primary objective of this study was to evaluate the associations between centre/country-based factors and two important process and outcome indicators in patients with hospital-acquired bloodstream infections (HABSI). Methods: We used data on HABSI from the prospective EUROBACT-2 study to evaluate the associations between centre/country factors on a process or an outcome indicator: adequacy of antimicrobial therapy within the first 24 h or 28-day mortality, respectively. Mixed logistical models with clustering by centre identified factors associated with both indicators. Results: Two thousand two hundred nine patients from two hundred one intensive care units (ICUs) were included in forty-seven countries. Overall, 51% (n = 1128) of patients received an adequate antimicrobial therapy and the 28-day mortality was 38% (n = 839). The availability of therapeutic drug monitoring (TDM) for aminoglycosides everyday [odds ratio (OR) 1.48, 95% confidence interval (CI) 1.03-2.14] or within a few hours (OR 1.79, 95% CI 1.34-2.38), surveillance cultures for multidrug-resistant organism carriage performed weekly (OR 1.45, 95% CI 1.09-1.93), and increasing Human Development Index (HDI) values were associated with adequate antimicrobial therapy. The presence of intermediate care beds (OR 0.63, 95% CI 0.47-0.84), TDM for aminoglycoside available everyday (OR 0.66, 95% CI 0.44-1.00) or within a few hours (OR 0.51, 95% CI 0.37-0.70), 24/7 consultation of clinical pharmacists (OR 0.67, 95% CI 0.47-0.95), percentage of vancomycin-resistant enterococci (VRE) between 10% and 25% in the ICU (OR 1.67, 95% CI 1.00-2.80), and decreasing HDI values were associated with 28-day mortality. Conclusion: Centre/country factors should be targeted for future interventions to improve management strategies and outcome of HABSI in ICU patients

    Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

    Full text link
    Purpose In the critically ill, hospital-acquired bloodstream infections (HA-BSI) are associated with significant mortality. Granular data are required for optimizing management, and developing guidelines and clinical trials. Methods We carried out a prospective international cohort study of adult patients (≥ 18 years of age) with HA-BSI treated in intensive care units (ICUs) between June 2019 and February 2021. Results 2600 patients from 333 ICUs in 52 countries were included. 78% HA-BSI were ICU-acquired. Median Sequential Organ Failure Assessment (SOFA) score was 8 [IQR 5; 11] at HA-BSI diagnosis. Most frequent sources of infection included pneumonia (26.7%) and intravascular catheters (26.4%). Most frequent pathogens were Gram-negative bacteria (59.0%), predominantly Klebsiella spp. (27.9%), Acinetobacter spp. (20.3%), Escherichia coli (15.8%), and Pseudomonas spp. (14.3%). Carbapenem resistance was present in 37.8%, 84.6%, 7.4%, and 33.2%, respectively. Difficult-to-treat resistance (DTR) was present in 23.5% and pan-drug resistance in 1.5%. Antimicrobial therapy was deemed adequate within 24 h for 51.5%. Antimicrobial resistance was associated with longer delays to adequate antimicrobial therapy. Source control was needed in 52.5% but not achieved in 18.2%. Mortality was 37.1%, and only 16.1% had been discharged alive from hospital by day-28. Conclusions HA-BSI was frequently caused by Gram-negative, carbapenem-resistant and DTR pathogens. Antimicrobial resistance led to delays in adequate antimicrobial therapy. Mortality was high, and at day-28 only a minority of the patients were discharged alive from the hospital. Prevention of antimicrobial resistance and focusing on adequate antimicrobial therapy and source control are important to optimize patient management and outcomes

    Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study

    Full text link
    Purpose: Older adults admitted to the intensive care unit (ICU) usually have fair baseline functional capacity, yet their age and frailty may compromise their management. We compared the characteristics and management of older (≥ 75 years) versus younger adults hospitalized in ICU with hospital-acquired bloodstream infection (HA-BSI). Methods: Nested cohort study within the EUROBACT-2 database, a multinational prospective cohort study including adults (≥ 18 years) hospitalized in the ICU during 2019-2021. We compared older versus younger adults in terms of infection characteristics (clinical signs and symptoms, source, and microbiological data), management (imaging, source control, antimicrobial therapy), and outcomes (28-day mortality and hospital discharge). Results: Among 2111 individuals hospitalized in 219 ICUs with HA-BSI, 563 (27%) were ≥ 75 years old. Compared to younger patients, these individuals had higher comorbidity score and lower functional capacity; presented more often with a pulmonary, urinary, or unknown HA-BSI source; and had lower heart rate, blood pressure and temperature at presentation. Pathogens and resistance rates were similar in both groups. Differences in management included mainly lower rates of effective source control achievement among aged individuals. Older adults also had significantly higher day-28 mortality (50% versus 34%, p < 0.001), and lower rates of discharge from hospital (12% versus 20%, p < 0.001) by this time. Conclusions: Older adults with HA-BSI hospitalized in ICU have different baseline characteristics and source of infection compared to younger patients. Management of older adults differs mainly by lower probability to achieve source control. This should be targeted to improve outcomes among older ICU patients

    Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

    Get PDF
    Background Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks. Methods The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned. Results A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P < 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31). Conclusion Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)
    corecore